Watertime, Author at PsyNews.com

Home Authors Posts by Watertime

549 POSTS 0 COMMENTS

Inside the World’s Most Active Psychedelic Therapy Site: A Conversation with...

Erica Siegal LCSW – NEST and SHINE Collective

LIVESTREAM: Alaska Natural Medicine

Pα+ Psychedelic Bulletin #190: ‘Europe’s Most Feared Investor’ Teams Up with...

A Rundown of Colorado’s Natural Medicine Program

SXSW Psychedelics Conference 2025

Psychedelic Culture by Chacruna Institute

Bicycle Day 2025 @ Meow Wolf Denver

Forging a Path to Access: Congressmen Correa and Bergman on the...

Neil Markey – Beckley Retreats

1...414243...55 Page 42 of 55

EDITOR PICKS

The Best Psychedelic Education Does Not Look Psychedelic

Pα+ Psychedelic Bulletin #230: Pharma Ramps Up Ad Spend on Psychedelic...

A Closer Look at Definium’s Phase 3 LSD for GAD Readout

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Watertime